{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"dopa-responsive-dystonia-due-to-sepiapterin-reductase-deficiency","columns":[{"gene":"","key":"population-a68388d66da0e6a9f93d","label":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","mondoId":"MONDO:0012994","onsetQualifier":null,"originColumnKey":"MONDO:0012994/OMIM:612716","originalViews":[{"key":"MONDO:0012994/OMIM:612716","label":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","scopeLabel":"OMIM:612716","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["218ec080e3d968fbc80758374ee092654fb2b0bf723b5f7e958a52a0c1aec247","39ecabfb94d975baa556a0c5a547f48cf67036ed983bed51fce9c596f342a110","3b7352a7185f848456d78689db4147a4968d52208a8d83ba7d0109c889444528","3c50e5e7f052199adf73bf3aa6f5d1239375b239eace6eaf3a3c0a3bf670b6c0","3cf0a0400ae4def9ce37f1877ea7938c26f62ae00140fccbc4c683b59ff3c769","41d5583afad67f9b64c57d048a4187921ad92545dd40397d56af4749ce22b412","462c7b819b79cf59747d87452c2dcd00df168458143af8826a9ea2ca2a69ad30","69b643ebc02532244cd69d4c422b6cf0d72c649622236f7b79d66e1e5a512dd1","74601fbf827c29cc7da2b88da9d1ec1824a38ca9e3398aba8c8aeef9b0fc83c9","7f7dd24f1c621c07f0cd2be7daffc19d4625b730f8b1736b28e77d81eef6b014","83a5f5d2b3edbc372a605a97f274b267fac623c08e911dc6d6efdd60572416cf","92a3d511032e5e635396de6a2a51a238fb17634a1f526434d70fe112ed521c3a","a35d810dd50b0ee76db06a88ee8dc783f44b6acbd656d38bd5b7411f770e5a2b","a93fbded9798dc8db8cd40c12ebae56e01636315ad3f4d4d1d34314071e235f6","ac2ecd98ea26ee89851001927cc32cca6ad0e2bf310962b27876d4f9cf7f7fa8","b581a2aed1aa058dc2a8c55611c7edd890a2118f1f005a3d206c2ce92344a823","c4182bf1e37526271ccaacdd408b711bbf44c1b7101d11df9b4748921bca5366","c850671a3a6f58a767b0f5431616a0097ff253fdce9f2b111fc180f1d69f1ae9","caf09db5a8a9cc9cdaa7e3d1eea5d28884caf74b58e0f6a511d53825375a2157","ccb11312f3c317a3a90e6bdc07324ae482b15b4b1d336709f760aa3705977ba5","e68252a3d6ed324e2666d4ac9f36d51a2944ce991c020c8eae6605b03bb8692a","e6db77c30d10cf8a32f122a053b1fcc79602c3be700bb63ccd561f671efd36a5","ebb1235c30eb153dccf60dd30f98c88ac48fe6df5b6236cd69fa1da94a46054a","fb082651508dfa3b1c52efad5f5a2db2d46266af0cffb8378e7606144d286b2e"],"recordQualifiers":{},"scopeLabel":"OMIM:612716","sourceIds":["OMIM:612716"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-4e74a1a12c32ad43bf7e","label":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","mondoId":"MONDO:0012994","onsetQualifier":null,"originColumnKey":"MONDO:0012994/ORPHA:70594","originalViews":[{"key":"MONDO:0012994/ORPHA:70594","label":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","scopeLabel":"ORPHA:70594","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1dbfb28b7e134b33ff7f14eeb309d590f3ec72b4eabf5c4da7742c0cfffee9cd","24fcbf86d3af0f4b96100da8aa3011dfd13cde7b5ed5caa98b6611ebe56a73c0","28e09280701a42701f3112d908dd7d25fcc509a2b5df9da7f5a2dea2b61fb9ce","28fb521b708b1baab6ca8251710311d105f9e2f5a65dbdcfa4991a6cc32c0b8f","3ae4390e7cf461d23d6d6d6757ac2b684700da7311b6e1078768b14ec69f83ee","4b15c1e198174d8de33d899034f0818963335f648f51136f5decd7fa0abf2b73","5470685699c93aad7a323180fa8ce9ef808111a320228dabdcf6e5b945b8075a","6c65e0857fb93ce43fe2a64beafe9c6026ac3678e55af1187422c844689d54b6","70b9266e1ffd094f8fbcc153d6d7800deba2b511ba9c043e47644a55a7ff6d6d","7646d95e9216f9e7a7ba098419c0c280d3977ec233089881c2004fa98526aca3","7dcbba70b4386208206b30df1a79454fb5c828272b60f7e3a3a4ecfc0d541577","8039d43b9f37016d5cb64607dba85c742c49d1b7fc1b814ed5c5dd867927f514","8618d5d3dd679d22573994a684468ff072c9a20181b7ea698c94ab4c79899175","909ef9b990c7510f2992a8fb5b55f8c6479f03e2a4e12e5143faea547acc3dae","94a858516c150c2e62c32133efd5c299bd3a6afd92cd8493d933a2083685ee1c","a547259d1df1c6b0f01766a6ab382b116ba81bc11aa629ad99961cf67b886e8c","ae640fa6eea835dd8517400d8da3240ed65883d47fa1d1f2b25f2f1413d7b4b8","b4b5e8ad112f7d4aa4ecf4a0065aa98f384f921ebab8093c1409075304959a5b","c07681b6e88b5adecadc1f88390682f53e0940faed8ae9ccc8bc6c8bbef86782","d1b005395f7f4b44b2b873a0aa4a4e51a4de185b4453e2030081c4cdb433c4ae","dcc4dc98504515ccac27784f03e6f07232a6afc1bcba8a10b07127df85f02e4e","e528ff102b5fbc137bca54429477d8c7609be1efdfc407b3792bb7c1cf5e1eaf","ed2e40aa51776d05d9a03b4bab43381d422245175f07480992609034d08bcbcf","fc282cbfebdfb81ddb1cd3af91bcab0ce74cd884f59229afcf67a4a931e4b057","fec7b80a70e21e96ca641004df332b1df47c0f2dcd4a5e325e5dd561d3fdc9c1","ff57a76235504a3362ef999d82182f8e8fa5427bc594cb58f0a3e7540606e80e"],"recordQualifiers":{},"scopeLabel":"ORPHA:70594","sourceIds":["ORPHA:70594"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a68388d66da0e6a9f93d","population-4e74a1a12c32ad43bf7e"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040210","HP:0040206","HP:0000366","HP:0000718","HP:0001251","HP:0000708","HP:0008936"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":15,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":50,"sourceGroups":{"omim":9,"orphanet":26,"published":15}},"features":[{"hpoId":"HP:0040210","label":"Abnormal circulating biopterin concentration","primary":true},{"hpoId":"HP:0040206","label":"Abnormal circulating neopterin concentration","primary":true},{"hpoId":"HP:0000366","label":"Abnormality of the nose","primary":true},{"hpoId":"HP:0000718","label":"Aggressive behavior","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0008936","label":"Axial hypotonia","primary":true},{"hpoId":"HP:0002067","label":"Bradykinesia","primary":false},{"hpoId":"HP:0100021","label":"Cerebral palsy","primary":false},{"hpoId":"HP:0001266","label":"Choreoathetosis","primary":false},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":false},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":false},{"hpoId":"HP:0000716","label":"Depression","primary":false},{"hpoId":"HP:0002329","label":"Drowsiness","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0001332","label":"Dystonia","primary":false},{"hpoId":"HP:0002359","label":"Frequent falls","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0000752","label":"Hyperactivity","primary":false},{"hpoId":"HP:0000975","label":"Hyperhidrosis","primary":false},{"hpoId":"HP:0004923","label":"Hyperphenylalaninemia","primary":false},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":false},{"hpoId":"HP:0000338","label":"Hypomimic face","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0002509","label":"Limb hypertonia","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0001270","label":"Motor delay","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0010553","label":"Oculogyric crisis","primary":false},{"hpoId":"HP:0000657","label":"Oculomotor apraxia","primary":false},{"hpoId":"HP:0000508","label":"Ptosis","primary":false},{"hpoId":"HP:6000563","label":"Reduced sepiapterin reductase activity in cultured fibroblasts","primary":false},{"hpoId":"HP:0002063","label":"Rigidity","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0002360","label":"Sleep disturbance","primary":false},{"hpoId":"HP:0001518","label":"Small for gestational age","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0005968","label":"Temperature instability","primary":false},{"hpoId":"HP:0008297","label":"Transient hyperphenylalaninemia","primary":false},{"hpoId":"HP:0001337","label":"Tremor","primary":false}],"ledeHtml":"Sepiapterin reductase deficiency is a condition characterized by movement problems, most often a pattern of involuntary, sustained muscle contractions known as dystonia. Other movement problems can include muscle stiffness (spasticity), tremors, problems with coordination and balance (ataxia), and involuntary jerking movements (chorea). People with sepiapterin reductase deficiency can experience episodes called oculogyric crises. These episodes involve abnormal rotation of the eyeballs; extreme irritability and agitation; and pain, muscle spasms, and uncontrolled movements, especially of the head and neck. Movement abnormalities are often worse late in the day. Most affected individuals have delayed development of motor skills such as sitting and crawling, and they typically are not able to walk unassisted. The problems with movement tend to worsen over time. People with sepiapterin reductase deficiency may have additional signs and symptoms including an unusually small head size (microcephaly), intellectual disability, seizures, excessive sleeping, and mood swings.","mondoId":"MONDO:0012994","node":{"canonicalSlug":"dopa-responsive-dystonia-due-to-sepiapterin-reductase-deficiency","comparisons":[{"documentSha256":"5efc261186033443c9d95ca9bec81a74ecaa68d2efbf73721dd065a0a4fdf94d","key":"legacy-dopa-responsive-dystonia","kind":"legacy","label":"dopa-responsive dystonia","memberIds":["MONDO:0007495","MONDO:0011551","MONDO:0012994","MONDO:0016812","MONDO:0859257","MONDO:0971063"],"mondoId":"MONDO:0016812","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/dopa-responsive-dystonia.5efc261186033443c9d95ca9bec81a74ecaa68d2efbf73721dd065a0a4fdf94d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","originalSourceId":"ORPHA:70594","paragraphs":["Sepiapterin reductase deficiency is a condition characterized by movement problems, most often a pattern of involuntary, sustained muscle contractions known as dystonia. Other movement problems can include muscle stiffness (spasticity), tremors, problems with coordination and balance (ataxia), and involuntary jerking movements (chorea). People with sepiapterin reductase deficiency can experience episodes called oculogyric crises. These episodes involve abnormal rotation of the eyeballs; extreme irritability and agitation; and pain, muscle spasms, and uncontrolled movements, especially of the head and neck. Movement abnormalities are often worse late in the day. Most affected individuals have delayed development of motor skills such as sitting and crawling, and they typically are not able to walk unassisted. The problems with movement tend to worsen over time. People with sepiapterin reductase deficiency may have additional signs and symptoms including an unusually small head size (microcephaly), intellectual disability, seizures, excessive sleeping, and mood swings."],"rawAttribution":"MONDO:0012994","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:06Z","upstream":"GARD:0010365","url":"https://rarediseases.info.nih.gov/diseases/10365"},"ownColumnKeys":["population-a68388d66da0e6a9f93d","population-4e74a1a12c32ad43bf7e"],"publication":"published","relationships":[{"kind":"parent","label":"dopa-responsive dystonia","mondoId":"MONDO:0016812","slug":"dopa-responsive-dystonia"},{"kind":"parent","label":"inherited dystonia","mondoId":"MONDO:0044807","slug":"inherited-dystonia"},{"kind":"parent","label":"tetrahydrobiopterin metabolic process disease","mondoId":"MONDO:0045014","slug":"tetrahydrobiopterin-metabolic-process-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/sepiapterin-reductase-deficiency"}],"translation":"published"},"records":[{"frequencyKind":"range","key":"1dbfb28b7e134b33ff7f14eeb309d590f3ec72b4eabf5c4da7742c0cfffee9cd","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"218ec080e3d968fbc80758374ee092654fb2b0bf723b5f7e958a52a0c1aec247","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"24fcbf86d3af0f4b96100da8aa3011dfd13cde7b5ed5caa98b6611ebe56a73c0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002067","is_excluded":false,"label":"Bradykinesia","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"28e09280701a42701f3112d908dd7d25fcc509a2b5df9da7f5a2dea2b61fb9ce","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000508","is_excluded":false,"label":"Ptosis","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"28fb521b708b1baab6ca8251710311d105f9e2f5a65dbdcfa4991a6cc32c0b8f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008936","is_excluded":false,"label":"Axial hypotonia","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"39ecabfb94d975baa556a0c5a547f48cf67036ed983bed51fce9c596f342a110","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008936","is_excluded":false,"label":"Axial hypotonia","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"3ae4390e7cf461d23d6d6d6757ac2b684700da7311b6e1078768b14ec69f83ee","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"3b7352a7185f848456d78689db4147a4968d52208a8d83ba7d0109c889444528","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"0/2","hpo_id":"HP:0040206","is_excluded":true,"label":"Abnormal circulating neopterin concentration","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3c50e5e7f052199adf73bf3aa6f5d1239375b239eace6eaf3a3c0a3bf670b6c0","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"9/9","hpo_id":"HP:6000563","is_excluded":false,"label":"Reduced sepiapterin reductase activity in cultured fibroblasts","onset_id":null,"reference":"PMID:22522443","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3cf0a0400ae4def9ce37f1877ea7938c26f62ae00140fccbc4c683b59ff3c769","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002359","is_excluded":false,"label":"Frequent falls","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"41d5583afad67f9b64c57d048a4187921ad92545dd40397d56af4749ce22b412","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"462c7b819b79cf59747d87452c2dcd00df168458143af8826a9ea2ca2a69ad30","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000657","is_excluded":false,"label":"Oculomotor apraxia","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4b15c1e198174d8de33d899034f0818963335f648f51136f5decd7fa0abf2b73","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5470685699c93aad7a323180fa8ce9ef808111a320228dabdcf6e5b945b8075a","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000975","is_excluded":false,"label":"Hyperhidrosis","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"69b643ebc02532244cd69d4c422b6cf0d72c649622236f7b79d66e1e5a512dd1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001337","is_excluded":false,"label":"Tremor","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"6c65e0857fb93ce43fe2a64beafe9c6026ac3678e55af1187422c844689d54b6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"70b9266e1ffd094f8fbcc153d6d7800deba2b511ba9c043e47644a55a7ff6d6d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"74601fbf827c29cc7da2b88da9d1ec1824a38ca9e3398aba8c8aeef9b0fc83c9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0008297","is_excluded":false,"label":"Transient hyperphenylalaninemia","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"7646d95e9216f9e7a7ba098419c0c280d3977ec233089881c2004fa98526aca3","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001518","is_excluded":false,"label":"Small for gestational age","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7dcbba70b4386208206b30df1a79454fb5c828272b60f7e3a3a4ecfc0d541577","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"7f7dd24f1c621c07f0cd2be7daffc19d4625b730f8b1736b28e77d81eef6b014","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"8039d43b9f37016d5cb64607dba85c742c49d1b7fc1b814ed5c5dd867927f514","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"83a5f5d2b3edbc372a605a97f274b267fac623c08e911dc6d6efdd60572416cf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0010553","is_excluded":false,"label":"Oculogyric crisis","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"8618d5d3dd679d22573994a684468ff072c9a20181b7ea698c94ab4c79899175","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002509","is_excluded":false,"label":"Limb hypertonia","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"909ef9b990c7510f2992a8fb5b55f8c6479f03e2a4e12e5143faea547acc3dae","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000366","is_excluded":false,"label":"Abnormality of the nose","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"92a3d511032e5e635396de6a2a51a238fb17634a1f526434d70fe112ed521c3a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"94a858516c150c2e62c32133efd5c299bd3a6afd92cd8493d933a2083685ee1c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100021","is_excluded":false,"label":"Cerebral palsy","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a35d810dd50b0ee76db06a88ee8dc783f44b6acbd656d38bd5b7411f770e5a2b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002360","is_excluded":false,"label":"Sleep disturbance","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a547259d1df1c6b0f01766a6ab382b116ba81bc11aa629ad99961cf67b886e8c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"a93fbded9798dc8db8cd40c12ebae56e01636315ad3f4d4d1d34314071e235f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ac2ecd98ea26ee89851001927cc32cca6ad0e2bf310962b27876d4f9cf7f7fa8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000752","is_excluded":false,"label":"Hyperactivity","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"ae640fa6eea835dd8517400d8da3240ed65883d47fa1d1f2b25f2f1413d7b4b8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0005968","is_excluded":false,"label":"Temperature instability","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b4b5e8ad112f7d4aa4ecf4a0065aa98f384f921ebab8093c1409075304959a5b","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000338","is_excluded":false,"label":"Hypomimic face","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"b581a2aed1aa058dc2a8c55611c7edd890a2118f1f005a3d206c2ce92344a823","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000718","is_excluded":false,"label":"Aggressive behavior","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"c07681b6e88b5adecadc1f88390682f53e0940faed8ae9ccc8bc6c8bbef86782","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0010553","is_excluded":false,"label":"Oculogyric crisis","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"c4182bf1e37526271ccaacdd408b711bbf44c1b7101d11df9b4748921bca5366","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c850671a3a6f58a767b0f5431616a0097ff253fdce9f2b111fc180f1d69f1ae9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"0/2","hpo_id":"HP:0040210","is_excluded":true,"label":"Abnormal circulating biopterin concentration","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"caf09db5a8a9cc9cdaa7e3d1eea5d28884caf74b58e0f6a511d53825375a2157","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ccb11312f3c317a3a90e6bdc07324ae482b15b4b1d336709f760aa3705977ba5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001266","is_excluded":false,"label":"Choreoathetosis","onset_id":null,"reference":"OMIM:612716","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d1b005395f7f4b44b2b873a0aa4a4e51a4de185b4453e2030081c4cdb433c4ae","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002063","is_excluded":false,"label":"Rigidity","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"dcc4dc98504515ccac27784f03e6f07232a6afc1bcba8a10b07127df85f02e4e","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e528ff102b5fbc137bca54429477d8c7609be1efdfc407b3792bb7c1cf5e1eaf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002360","is_excluded":false,"label":"Sleep disturbance","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e68252a3d6ed324e2666d4ac9f36d51a2944ce991c020c8eae6605b03bb8692a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e6db77c30d10cf8a32f122a053b1fcc79602c3be700bb63ccd561f671efd36a5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000716","is_excluded":false,"label":"Depression","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ebb1235c30eb153dccf60dd30f98c88ac48fe6df5b6236cd69fa1da94a46054a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"ed2e40aa51776d05d9a03b4bab43381d422245175f07480992609034d08bcbcf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"fb082651508dfa3b1c52efad5f5a2db2d46266af0cffb8378e7606144d286b2e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:612716","disease_name":"Dystonia, dopa-responsive, due to sepiapterin reductase deficiency","evidence":"PCS","frequency_raw":"0/2","hpo_id":"HP:0004923","is_excluded":true,"label":"Hyperphenylalaninemia","onset_id":null,"reference":"PMID:11443547","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fc282cbfebdfb81ddb1cd3af91bcab0ce74cd884f59229afcf67a4a931e4b057","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"fec7b80a70e21e96ca641004df332b1df47c0f2dcd4a5e325e5dd561d3fdc9c1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002329","is_excluded":false,"label":"Drowsiness","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ff57a76235504a3362ef999d82182f8e8fa5427bc594cb58f0a3e7540606e80e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:70594","disease_name":"Dopa-responsive dystonia due to sepiapterin reductase deficiency","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001337","is_excluded":false,"label":"Tremor","onset_id":null,"reference":"ORPHA:70594","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10365\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012994\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0010365</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Sepiapterin reductase deficiency is a condition characterized by movement problems, most often a pattern of involuntary, sustained muscle contractions known as dystonia. Other movement problems can include muscle stiffness (spasticity), tremors, problems with coordination and balance (ataxia), and involuntary jerking movements (chorea). People with sepiapterin reductase deficiency can experience episodes called oculogyric crises. These episodes involve abnormal rotation of the eyeballs; extreme irritability and agitation; and pain, muscle spasms, and uncontrolled movements, especially of the head and neck. Movement abnormalities are often worse late in the day. Most affected individuals have delayed development of motor skills such as sitting and crawling, and they typically are not able to walk unassisted. The problems with movement tend to worsen over time. People with sepiapterin reductase deficiency may have additional signs and symptoms including an unusually small head size (microcephaly), intellectual disability, seizures, excessive sleeping, and mood swings.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10365\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"dopa-responsive-dystonia-due-to-sepiapterin-reductase-deficiency","sourceDocuments":[{"name":"GARD: Dopa-responsive dystonia due to sepiapterin reductase deficiency","reviewed":null,"source_release":"2026-10-25T03:41:06Z","url":"https://rarediseases.info.nih.gov/diseases/10365"},{"name":"MONDO: dopa-responsive dystonia due to sepiapterin reductase deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012994"}],"sourceNote":"","synonyms":["autosomal recessive sepiapterin reductase-deficient DRD","dopa-responsive dystonia due to sepiapterin reductase deficiency","DRD due to SRD","DYT-SPR","Sepiapterin Reductase Deficiency","sepiapterin reductase deficiency","SPR deficiency","SRD"],"takeawayHtml":"","title":"dopa-responsive dystonia due to sepiapterin reductase deficiency"},"schemaVersion":1}
